Literature DB >> 17152078

Does tetracycline bind helix 2 of prion? An integrated spectroscopical and computational study of the interaction between the antibiotic and alpha helix 2 human prion protein fragments.

Luisa Ronga1, Emma Langella, Pasquale Palladino, Daniela Marasco, Barbara Tizzano, Michele Saviano, Carlo Pedone, Roberto Improta, Menotti Ruvo.   

Abstract

We demonstrate here that tetracycline (TC) can strongly interact (KD' = 189 +/- 7 nM) with model peptides derived from the C-terminal globular domain of the prion protein, hPrP [173-195], and that interaction concerns residues within the C-terminal half of the helix 2, a short region previously indicated as endowed with ambivalent conformational behavior and implicated in PrP conversion to the beta-sheet-rich, infective scrapie variant. Data have been confirmed by binding studies with the N-terminal truncated 180-195 variant that displays a dissociation constant of 483 +/- 30 nM. Remarkably, TC does not influence the structure of the N-terminally fluoresceinated peptides that both show alpha-helical conformations. Docking calculations and molecular dynamics simulations suggest a direct, strong interaction of the antibiotic with exposed side chain functional groups of threonines 190-193 on the solvent-exposed surface of helix 2. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17152078     DOI: 10.1002/prot.21204

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  7 in total

1.  Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231.

Authors:  Alessandro Corsaro; Stefano Thellung; Katia Chiovitti; Valentina Villa; Alessandro Simi; Federica Raggi; Domenico Paludi; Claudio Russo; Antonio Aceto; Tullio Florio
Journal:  Neurotox Res       Date:  2009-02-26       Impact factor: 3.911

2.  The anti-fibrillogenic activity of tetracyclines on PrP 106-126: a 3D-QSAR study.

Authors:  Ugo Cosentino; Demetrio Pitea; Giorgio Moro; Gloria A A Saracino; Pietro Caria; Rosaria M Varì; Laura Colombo; Gianluigi Forloni; Fabrizio Tagliavini; Mario Salmona
Journal:  J Mol Model       Date:  2008-07-16       Impact factor: 1.810

3.  Gold complexes inhibit the aggregation of prion neuropeptides.

Authors:  Xuesong Wang; Lei He; Cong Zhao; Weihong Du; Jun Lin
Journal:  J Biol Inorg Chem       Date:  2013-08-28       Impact factor: 3.358

4.  The role of the unusual threonine string in the conversion of prion protein.

Authors:  Romany Abskharon; Fei Wang; Kayla J Vander Stel; Kumar Sinniah; Jiyan Ma
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

5.  Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2'-pyridyl)benzimidazole Ligands.

Authors:  Daniele Florio; Ilaria Iacobucci; Giarita Ferraro; Ahmed M Mansour; Giancarlo Morelli; Maria Monti; Antonello Merlino; Daniela Marasco
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-12

6.  NMR structure and CD titration with metal cations of human prion alpha2-helix-related peptides.

Authors:  Luisa Ronga; Pasquale Palladino; Gabriella Saviano; Teodorico Tancredi; Ettore Benedetti; Raffaele Ragone; Filomena Rossi
Journal:  Bioinorg Chem Appl       Date:  2007       Impact factor: 7.778

Review 7.  Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms.

Authors:  Sofia Giorgetti; Claudio Greco; Paolo Tortora; Francesco Antonio Aprile
Journal:  Int J Mol Sci       Date:  2018-09-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.